Cargando…

Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome

Background and Aims. Although the differential expression of microRNA (miRNA) genes has been identified in many diseases, little information exists concerning the miRNA expression profile in type 2 diabetes mellitus (T2DM) with diarrhea-predominant irritable bowel syndrome (D-IBS). Therefore, the sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Wenhua, Dong, Xiaoyun, Kong, Guimei, Fang, Penghua, Huang, Xiaoli, Bo, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011218/
https://www.ncbi.nlm.nih.gov/pubmed/27635130
http://dx.doi.org/10.1155/2016/9256209
_version_ 1782451787059429376
author Tao, Wenhua
Dong, Xiaoyun
Kong, Guimei
Fang, Penghua
Huang, Xiaoli
Bo, Ping
author_facet Tao, Wenhua
Dong, Xiaoyun
Kong, Guimei
Fang, Penghua
Huang, Xiaoli
Bo, Ping
author_sort Tao, Wenhua
collection PubMed
description Background and Aims. Although the differential expression of microRNA (miRNA) genes has been identified in many diseases, little information exists concerning the miRNA expression profile in type 2 diabetes mellitus (T2DM) with diarrhea-predominant irritable bowel syndrome (D-IBS). Therefore, the specific expression of miRNAs in diabetes with D-IBS is identified in the study. Materials and Methods. 201 patients with IBS and 220 matched healthy controls were included in the study. Microarray technology and real-time reverse transcriptase-polymerase chain reaction analysis (RT-PCR) were taken to examine the miRNA expression profiles of T2DM patients with diarrhea-predominant irritable bowel syndrome (D-IBS) compared with patients with T2DM, patients with D-IBS, and control subjects. Results. We have found that 35 miRNAs were differentially expressed in T2DM with D-IBS, in which three representative miRNAs, hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b, were found to be significantly elevated in T2DM with D-IBS by RT-PCR. Conclusions. Our study has indicated that hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b were elevated in T2DM with D-IBS, which may be the potential biomarkers of T2DM with D-IBS. To obtain a better understanding of the biological functions of these miRNAs in T2DM with D-IBS, functional annotation analysis suggested that the MAPK pathway may be responsible for T2DM with D-IBS.
format Online
Article
Text
id pubmed-5011218
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-50112182016-09-15 Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome Tao, Wenhua Dong, Xiaoyun Kong, Guimei Fang, Penghua Huang, Xiaoli Bo, Ping Gastroenterol Res Pract Research Article Background and Aims. Although the differential expression of microRNA (miRNA) genes has been identified in many diseases, little information exists concerning the miRNA expression profile in type 2 diabetes mellitus (T2DM) with diarrhea-predominant irritable bowel syndrome (D-IBS). Therefore, the specific expression of miRNAs in diabetes with D-IBS is identified in the study. Materials and Methods. 201 patients with IBS and 220 matched healthy controls were included in the study. Microarray technology and real-time reverse transcriptase-polymerase chain reaction analysis (RT-PCR) were taken to examine the miRNA expression profiles of T2DM patients with diarrhea-predominant irritable bowel syndrome (D-IBS) compared with patients with T2DM, patients with D-IBS, and control subjects. Results. We have found that 35 miRNAs were differentially expressed in T2DM with D-IBS, in which three representative miRNAs, hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b, were found to be significantly elevated in T2DM with D-IBS by RT-PCR. Conclusions. Our study has indicated that hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b were elevated in T2DM with D-IBS, which may be the potential biomarkers of T2DM with D-IBS. To obtain a better understanding of the biological functions of these miRNAs in T2DM with D-IBS, functional annotation analysis suggested that the MAPK pathway may be responsible for T2DM with D-IBS. Hindawi Publishing Corporation 2016 2016-08-22 /pmc/articles/PMC5011218/ /pubmed/27635130 http://dx.doi.org/10.1155/2016/9256209 Text en Copyright © 2016 Wenhua Tao et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tao, Wenhua
Dong, Xiaoyun
Kong, Guimei
Fang, Penghua
Huang, Xiaoli
Bo, Ping
Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
title Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
title_full Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
title_fullStr Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
title_full_unstemmed Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
title_short Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
title_sort elevated circulating hsa-mir-106b, hsa-mir-26a, and hsa-mir-29b in type 2 diabetes mellitus with diarrhea-predominant irritable bowel syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011218/
https://www.ncbi.nlm.nih.gov/pubmed/27635130
http://dx.doi.org/10.1155/2016/9256209
work_keys_str_mv AT taowenhua elevatedcirculatinghsamir106bhsamir26aandhsamir29bintype2diabetesmellituswithdiarrheapredominantirritablebowelsyndrome
AT dongxiaoyun elevatedcirculatinghsamir106bhsamir26aandhsamir29bintype2diabetesmellituswithdiarrheapredominantirritablebowelsyndrome
AT kongguimei elevatedcirculatinghsamir106bhsamir26aandhsamir29bintype2diabetesmellituswithdiarrheapredominantirritablebowelsyndrome
AT fangpenghua elevatedcirculatinghsamir106bhsamir26aandhsamir29bintype2diabetesmellituswithdiarrheapredominantirritablebowelsyndrome
AT huangxiaoli elevatedcirculatinghsamir106bhsamir26aandhsamir29bintype2diabetesmellituswithdiarrheapredominantirritablebowelsyndrome
AT boping elevatedcirculatinghsamir106bhsamir26aandhsamir29bintype2diabetesmellituswithdiarrheapredominantirritablebowelsyndrome